欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/3862/004
药品名称Nistik 40 mg/5 mg/25 mg
活性成分
    • amlodipine 5.0 mg
    • hydrochlorothiazide 25.0 mg
    • olmesartan medoxomil 40.0 mg
剂型Film-coated tablet
上市许可持有人Menarini International O.L. S.A. 1, Avenue de la Gare L-1611 Luxembourg
参考成员国 - 产品名称Netherlands (NL)
Olmesartan/Amlodipine/HCT Daiichi Sankyo 40 mg/5 mg/25 mg filmomhulde tabletten
互认成员国 - 产品名称
    • Italy (IT)
许可日期2017/07/05
最近更新日期2023/05/25
药物ATC编码
    • C09DX03 olmesartan medoxomil, amlodipine and hydrochlorothiazide
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Informed Consent Art 10c Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase